TransMedics (TMDX) Preferred Stock Liabilities (2018 - 2019)
TransMedics' quarterly Preferred Stock Liabilities came in at $186.5 million in Q1 2019, little changed quarter-over-quarter from $186.5 million in Q4 2018.
TransMedics has reported Preferred Stock Liabilities for 2 years, with the latest figure at $186.5 million in Q1 2019.
- For the quarter ending Q1 2019, Preferred Stock Liabilities changed N/A year-over-year to $186.5 million; the trailing twelve-month figure through Mar 2019 stood at $186.5 million (changed N/A YoY), and the FY2018 full-year result was $186.5 million, changed N/A from the prior year.
- Preferred Stock Liabilities for Q1 2019 stood at $186.5 million, roughly flat from $186.5 million in the prior quarter.
- The five-year high for Preferred Stock Liabilities was $186.5 million in Q4 2018, with the low at $186.5 million in Q4 2018.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | TransMedics | 2.32 Bn | 1.86 Bn | 101.16 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 30, 2019 | 186.52 Mn |
| Dec 29, 2018 | 186.52 Mn |